Moderna Drops Vaccine for Birth Defects After Trial Failure

Moderna had hoped its shot would be at least 49% effective at preventing CMV infections, substantially reducing the risk of ...

Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025

Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it ...
Business Insider

Vaxart to Showcase its Norovirus and COVID-19 Oral Pill Vaccine Candidates at World Vaccine Congress Europe 2025

SOUTH SAN FRANCISCO, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant ...

So THAT's Why All The Kids Seem To Be Sick Right Now

Children aged 2-3 years old, as well as school-age children (reception to year 11) and children with certain long-term health ...
The Sudbury Star

Gifford-Jones: It may be flu season, but this is not the flu

The virus is found only in humans, not animals, and it doesn’t need much help to make trouble. A microscopic particle is ...